Inhibition of bacterial toxin recognition of membrane components as an anti-virulence strategy
Eric Krueger1, Angela C Brown1
1Department of Chemical and Biomolecular Engineering, Lehigh University, Bethlehem, PA 18015 USA.
Abstract:
Over recent years, the development of new antibiotics has not kept pace with the rate at which bacteria develop resistance to these drugs. For this reason, many research groups have begun to design and study alternative therapeutics, including molecules to specifically inhibit the virulence of pathogenic bacteria. Because many of these pathogenic bacteria release protein toxins, which cause or exacerbate disease, inhibition of the activity of bacterial toxins is a promising anti-virulence strategy. In this review, we describe several approaches to inhibit the initial interactions of bacterial toxins with host cell membrane components. The mechanisms by which toxins interact with the host cell membrane components have been well-studied over the years, leading to the identification of therapeutic targets, which have been exploited in the work described here. We review efforts to inhibit binding to protein receptors and essential membrane lipid components, complex assembly, and pore formation. Although none of these molecules have yet been demonstrated in clinical trials, the in vitro and in vivo results presented here demonstrate their promise as novel alternatives and/or complements to traditional antibiotics.
Insights
New therapeutic molecules aim to block bacterial toxins, offering a promising alternative to traditional antibiotics as antibiotic resistance grows. These anti-virulence strategies target toxin interactions with host cells, showing potential in early studies.
Area of Science:
- Microbiology
- Pharmacology
- Biochemistry
Background:
- Antibiotic resistance is a growing global health threat, outpacing the development of new antibiotics.
- Pathogenic bacteria utilize protein toxins to cause or worsen disease, making toxin inhibition a key anti-virulence strategy.
Purpose of the Study:
- To review novel therapeutic approaches targeting bacterial toxin interactions with host cell membranes.
- To explore strategies for inhibiting toxin binding, assembly, and pore formation.
Main Methods:
- Review of research on inhibiting initial toxin-host cell membrane interactions.
- Analysis of therapeutic targets identified through understanding toxin mechanisms.
- Examination of approaches including inhibiting protein receptor binding, lipid interactions, complex assembly, and pore formation.
Main Results:
- Several therapeutic strategies targeting bacterial toxins have been developed.
- In vitro and in vivo studies show promise for these novel anti-virulence agents.
- These molecules represent potential alternatives or complements to conventional antibiotics.
Conclusions:
- Inhibiting bacterial toxin activity is a viable anti-virulence strategy.
- Targeting toxin-host cell interactions offers a promising avenue for developing new therapeutics.
- While not yet in clinical trials, these approaches demonstrate significant potential against bacterial infections.
Related Concept Videos
01:22Waterproofing and Anti-Bacterial Admixtures in Concrete
Waterproofing admixtures render concrete hydrophobic,...
01:33Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
00:46Feedback Inhibition
01:36Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
01:23Components of Stress
Interestingly, the hidden cube faces also experience these stresses, equal and...
01:24Components of Language